Figure 2From: A randomised controlled phase II trial of pre-operative celecoxib treatment reveals anti-tumour transcriptional response in primary breast cancerqPCR validation of selected genes differentially expressed in celecoxib-treated samples as determined by microarray analysis. Fold-change and the 95% CI (error bars) are shown. Expression of six out of eight genes analysed (indicated by asterisks) was significantly changed in agreement with the microarray analysis.Back to article page